Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
about
Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB.Identification of natural compounds targeting Annexin A2 with an anti-cancer effect.Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes.
P2860
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
@en
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
@nl
type
label
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
@en
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
@nl
prefLabel
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
@en
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
@nl
P2093
P2860
P356
P1433
P1476
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.
@en
P2093
Brian Poligone
Carolina V Alexander-Savino
Jiyong Zhao
P2860
P304
75954-75967
P356
10.18632/ONCOTARGET.12488
P407
P577
2016-10-06T00:00:00Z